We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Office of Drug Safety to Use Data Mining to Analyze AERS
FDA's Office of Drug Safety to Use Data Mining to Analyze AERS
January 24, 2005
FDA drug safety reviewers should have a new data mining tool this spring to help them evaluate the hundreds of thousands of reports submitted annually to the Adverse Events Reporting System (AERS) — a system that is now more widely available to the public online.